Cufence 200 mg hard capsules
TR-004
Approved small_molecule active
Quick answer
Cufence 200 mg hard capsules for Wilson’s Disease is a Approved program (small_molecule) at Univar Solutions BV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Univar Solutions BV
- Indication
- Wilson’s Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active